Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Src inhibitors: genomics to therapeutics.

T Sawyer1, B Boyce, D Dalgarno

  • 1ARIAD Pharmaceuticals, Cambridge, MA 02139, USA.

Expert Opinion on Investigational Drugs
|January 5, 2002
PubMed
Summary

Developing Src inhibitor drugs shows promise for treating osteoporosis and cancer. Research highlights diverse chemical compounds and their effectiveness in preclinical models, paving the way for new therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid cycle deliberate practice improves resident performance during ELBW resuscitation.

Journal of neonatal-perinatal medicine·2024
Same author

Analgesic benefits of the quadratus lumborum block in total hip arthroplasty: a systematic review and meta-analysis.

Anaesthesia·2022
Same author

Strong exciton-plasmon coupling in dye-doped film on a planar hyperbolic metamaterial.

Optics letters·2020
Same author

Spaced learning versus massed learning in resuscitation - A systematic review.

Resuscitation·2020
Same author

Positive pressure ventilation coaching during neonatal bag-mask ventilation: A simulation-based pilot study.

Journal of neonatal-perinatal medicine·2019
Same author

Boot camps in neonatal-perinatal medicine fellowship programs: A national survey.

Journal of neonatal-perinatal medicine·2019

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Src is a key protein tyrosine kinase and oncogene.
  • Src is a validated therapeutic target for osteoporosis and cancer.
  • Intensive efforts are underway to develop Src inhibitor drugs.

Purpose of the Study:

  • To review the progress in developing Src inhibitor drugs.
  • To highlight chemical diversity and structure-based design of Src inhibitors.
  • To illustrate the in vitro and in vivo biological activities of Src inhibitors.

Main Methods:

  • Review of existing literature on Src inhibitors.
  • Analysis of chemical structures and design strategies.
  • Evaluation of in vitro and in vivo data on potency, selectivity, and efficacy.

Main Results:

  • Promising Src inhibitor lead compounds have been identified.
  • Inhibitors target both catalytic and non-catalytic domains of Src.
  • Key inhibitors demonstrate potent, selective, and effective activity in preclinical models.

Conclusions:

  • Src inhibitor drug development is nearing clinical application.
  • Current research is well-positioned for therapeutic breakthroughs.
  • Src inhibitors offer potential treatments for osteoporosis, cancer, and other diseases.

Related Experiment Videos